Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
CC transcript
Quarterly results
PURE BIOSCIENCE, INC. (PURE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 4 Rendall David (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.12, valued at $15k
08/03/2023 4 Myers Thomas Richard (COO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 150,000 options to buy @ $0.12, valued at $18k
08/03/2023 4 Lee Tom Y (CEO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.12, valued at $15k
08/03/2023 4 Elliott Mark Stuart (Vice President, Finance) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 150,000 options to buy @ $0.12, valued at $18k
08/03/2023 4 Chen Ivan (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 150,000 options to buy @ $0.12, valued at $18k
08/03/2023 4 Blotner Bernard (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.12, valued at $15k
08/03/2023 4 BARTLETT ROBERT F (CEO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 150,000 options to buy @ $0.12, valued at $18k
07/10/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CONVERTIBLE PROMISSORY NOTE",
"NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT is made as of June 30, 2023, by and among Pure Bioscience, Inc., a Delaware corporation , and the lenders named on Schedule 1 attached hereto . Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to them in Section 1 below. 1. Definitions . “ Action ” shall have the meaning ascribed to such term in Section 4.9 . “ Affiliate ” shall mean any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 144 under the Securities Act. With respect to a Lender, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as su..."
03/22/2023 4 Blotner Bernard (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Bought 10,000 shares @ $0.1299, valued at $1.3k
03/22/2023 4 BARTLETT ROBERT F (CEO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Bought 50,000 shares @ $0.155, valued at $7.8k
03/21/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/17/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/17/2023 8-K Quarterly results
Docs: "PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results"
02/22/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/21/2023 3 BARTLETT ROBERT F (Director) has filed a Form 3 on PURE BIOSCIENCE, INC.
02/10/2023 8-K Quarterly results
12/23/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/14/2022 8-K Quarterly results
10/28/2022 10-K Annual Report for the period ended July 31, 2022
10/28/2022 8-K Quarterly results
10/04/2022 4 Elliott Mark Stuart (Vice President, Finance) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 100,000 options to buy @ $0.2, valued at $20k
10/04/2022 4 Rendall David (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.2, valued at $25k
10/04/2022 4 Taylor Kristin (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.2, valued at $25k
10/04/2022 4 Myers Thomas Richard (COO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.2, valued at $25k
10/04/2022 4 Lee Tom Y (CEO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 125,000 options to buy @ $0.2, valued at $25k
Granted 200,000 options to buy @ $0.2, valued at $40k
10/04/2022 4 Chen Ivan (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 150,000 options to buy @ $0.2, valued at $30k
07/19/2022 4 Rendall David (Director) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 325,000 shares @ $0.15, valued at $48.8k
07/19/2022 4 Lee Tom Y (CEO) has filed a Form 4 on PURE BIOSCIENCE, INC.
Txns: Granted 15,741,666 shares @ $0.15, valued at $2.4M
Granted 6,000,000 shares @ $0.15, valued at $900k
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 8-K Quarterly results
06/14/2022 10-Q Quarterly Report for the period ended April 30, 2022
06/14/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy